Xilinx gains after getting Chinese approval for $35B sale to Advanced Micro Devices (update)
JHVEPhoto/iStock Editorial via Getty Images


Update 11:54am: Updates to add that the transaction doesn't need CFIUS approval.
Xilinx (NASDAQ:XLNX)
rose 5.9% after China's antitrust authority approved with conditions Advanced Micro Devices' (NASDAQ:AMD) planned $35B purchase of the company. AMD fell 0.8%.

China's State Administration for Market Regulation approved the deal, according to a listing on its website.

Chinese approval is a huge win for the deal as China was originally the last regulator that needed to approve the transaction before it can close. The deal now needs to get U.S. antitrust signoff after the agency had already approved the deal, though it had to be refiled after a year deadline passed.
Xilinx (XLNX) and AMD (AMD) disclosed in an 8-K filing this morning that the companies refiled for HSR on Jan. 10 and the deadline now expires on Feb. 9. Xilinx and AMD currently anticipate that the closing of the deal will occur in Q1, pending the expiration of the waiting period under the HSR Act.
The transaction does not require CFIUS approval, an AMD spokesman confirmed in an email with Seeking Alpha.
Yesterday, Xilinx Non-GAAP EPS of $1.29 beats by $0.27, revenue of $1.01B beats by $68.15M.